01/30/2020
In this podcast, David Alland, PhD, answers our questions about his research on drug-resistant tuberculosis, which may pave the way for future treatments for the disease.
David Alland, PhD, is the chief of Infectious Disease and the director of the Center for Emerging Pathogens at Rutgers New Jersey Medical School in Newark, New Jersey.
Additional Resource:
- Safi H, Gopal P, Lingaraju S, Alland D, et al. Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance [published online September 6, 2019]. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.1907631116.
